Arcadia Biosciences, Inc.
RKDA
$3.40
-$0.0813-2.34%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 17.69% | 4.06% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 17.69% | 4.06% | |||
| Cost of Revenue | 63.76% | -41.12% | |||
| Gross Profit | -27.00% | 306.75% | |||
| SG&A Expenses | -16.36% | -15.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.87% | -22.31% | |||
| Operating Income | 12.87% | 33.25% | |||
| Income Before Tax | -163.89% | 176.35% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -163.89% | 176.35% | |||
| Earnings from Discontinued Operations | 45.50% | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -251.93% | 143.79% | |||
| EBIT | 12.87% | 33.25% | |||
| EBITDA | 11.73% | 33.24% | |||
| EPS Basic | -251.83% | 143.75% | |||
| Normalized Basic EPS | 45.06% | 9.93% | |||
| EPS Diluted | -251.83% | 143.74% | |||
| Normalized Diluted EPS | 45.06% | 9.93% | |||
| Average Basic Shares Outstanding | 0.07% | 0.08% | |||
| Average Diluted Shares Outstanding | 0.07% | 0.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
